Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 1539

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 7
Chunk 1539
---
 believe that our audits provide
a reasonable basis for our opinion.

/s/ WithumSmith+Brown, PC

We have served as the Company's auditor since
2020.

New York, New York

April 22, 2025

PCAOB Number 100

F-2

OSR
HOLDINGS, INC.

(f/k/a Bellevue Life
Sciences Acquisition Corp.)

CONSOLIDATED
BALANCE SHEETS

    December 31,

    2024

    2023

    Assets

    Current assets:

    Cash
     
    $
    66,135

    $
    15,419

    Due from affiliate

    300,000

    -

    Prepaid expenses and other current assets

    89,263

    7,208

    Total current assets

    455,398

    22,627

    Investments held in Trust Account

    1,847,643

    36,605,106

    Total Assets
     
    $
    2,303,041

    $
    36,627,733

    Liabilities and Stockholders’ Deficit

    Current liabilities:

    Accounts payable and accrued expenses
     
    $
    2,882,012 

    $
    1,081,753

    Income taxes payable

    358,333

    524,562

    Excise tax payable

    843,464

    359,957

    Notes payable - related parties

    1,763,000

    -

    Due to affiliate

    72,000

    72,000

    Convertible note payable

    800,000

    -

    Total current liabilities

    6,718,809

    2,038,272

    Deferred underwriting commissions

    2,070,000

    2,070,000

    Total Liabilities

    8,788,809

    4,108,272

    Commitments and Contingencies

    Common stock subject to possible redemption, 164,752 shares issued and outstanding  at redemption value of $11.21 per share and 3,467,954 shares issued and outstanding  at redemption value of $10.50 per share at December 31, 2024 and 2023, respectively

    1,847,643

    36,426